Pancreatitis after endoscopic retrograde cholangiopancreatography: A narrative review

Acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is a feared and potentially fatal complication that can be as high as up to 30% in high-risk patients. Pre-examination measures, during the examination and after the examination are the key to technical and clinical success...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Igor Braga, do Monte Junior, Epifanio Silvino, Miranda Neto, Antonio Afonso, Proença, Igor Mendonça, de Moura, Diogo Turiani Hourneaux, Minata, Mauricio Kazuyoshi, Ide, Edson, dos Santos, Marcos Eduardo Lera, Luz, Gustavo de Oliveira, Matuguma, Sergio Eiji, Cheng, Spencer, Baracat, Renato, de Moura, Eduardo Guimarães Hourneaux
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160616/
https://www.ncbi.nlm.nih.gov/pubmed/34092971
http://dx.doi.org/10.3748/wjg.v27.i20.2495
Descripción
Sumario:Acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is a feared and potentially fatal complication that can be as high as up to 30% in high-risk patients. Pre-examination measures, during the examination and after the examination are the key to technical and clinical success with a decrease in adverse events. Several studies have debated on the subject, however, numerous topics remain controversial, such as the effectiveness of prophylactic medications and the amylase dosage time. This review was designed to provide an update on the current scientific evidence regarding PEP available in the literature.

Ejemplares similares